Larimar Therapeutics Stock Options

LRMR Stock  USD 6.57  0.19  2.81%   

Larimar Therapeutics Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Larimar Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Larimar Total Stockholder Equity

Total Stockholder Equity

73.02 Million

At this time, Larimar Therapeutics' Total Stockholder Equity is relatively stable compared to the past year.

Larimar Therapeutics Corporate Management

Gopi MBAChief OfficerProfile
DO SrChief OfficerProfile
Francis ConwayVP ControllerProfile
Sr DOChief OfficerProfile
John BermanVice AdministrationProfile

Additional Tools for Larimar Stock Analysis

When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.